Antinuclear Antibody (ANA) Testing Protocol



This protocol describes the appropriate use of antinuclear antibody (ANA) testing in the diagnosis of connective tissue disease (CTD) in adults aged ≥ 19 years. The protocol does NOT address ANA testing in the investigation of unexplained infertility, adverse pregnancy outcomes, liver disease or thrombotic disorders.

Comments: (0)